Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptive Biotechnologies ...

    NASDAQ: ADPT · Real-Time Price · USD
    9.51
    0.20 (2.15%)
    At close: May 30, 2025, 3:59 PM
    9.51
    0.00%
    After-hours: May 30, 2025, 05:16 PM EDT
    2.15%
    Bid 8.5
    Market Cap 1.44B
    Revenue (ttm) 189.53M
    Net Income (ttm) -141.84M
    EPS (ttm) -0.97
    PE Ratio (ttm) -9.8
    Forward PE -14.09
    Analyst Buy
    Ask 9.81
    Volume 1,292,339
    Avg. Volume (20D) 2,326,167
    Open 9.19
    Previous Close 9.31
    Day's Range 9.07 - 9.61
    52-Week Range 2.99 - 10.28
    Beta 1.76

    About ADPT

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ADPT
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ADPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    4 weeks ago
    +33.7%
    Adaptive Biotechnologies shares are trading higher... Unlock content with Pro Subscription
    4 weeks ago
    +0%
    Adaptive Biotechnologies shares are trading higher after the company reported better-than-expected Q1 financial results.
    news image

    4 days ago · zacks.com

    Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

    Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.

    news image

    3 weeks ago · zacks.com

    Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?

    Does Adaptive Biotechnologies (ADPT) have what it takes to be a top stock pick for momentum investors? Let's find out.

    news image

    3 weeks ago · zacks.com

    Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?

    The consensus price target hints at a 26.5% upside potential for Adaptive Biotechnologies (ADPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in e...

    news image

    3 weeks ago · zacks.com

    Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

    Here is how Adaptive Biotechnologies (ADPT) and Centene (CNC) have performed compared to their sector so far this year.

    news image

    4 weeks ago · seekingalpha.com

    Adaptive Biotechnologies Corporation (ADPT) Q1 2025 Earnings Call Transcript

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Karina Calzadilla - Head of Investor Relations & FP&A Chad Robins - Chi...

    news image

    4 weeks ago · zacks.com

    Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

    The headline numbers for Adaptive Biotechnologies (ADPT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wal...

    news image

    1 month ago · zacks.com

    Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

    Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.

    Add to Watchlist